Volume 19, Issue 4, April 2025

IL-23R-Specific Chimeric Antigen Receptor Tregs in Crohn’s Disease: Dawn of a Cellular Immunotherapeutic Era?

• Extract
• View article

Association of the HLA-DQA1*05 Allelic Gene Variants with Immunogenicity to Anti-TNF therapeutics—Important Differences Between Infliximab and Adalimumab

• Extract
• View article

Higher dietary glycemic index, but not glycemic load, is associated with increased risk of ulcerative colitis: a prospective cohort study

• Abstracts
• View article
• Supplementary data

Corticosteroid-sparing effects of risankizumab efficacy and safety in patients with moderately to severely active ulcerative colitis

• Abstracts
• View article
• Supplementary data

Artificial intelligence-assisted approach to assessing bowel wall thickness in pediatric inflammatory bowel disease using intestinal ultrasound images

• Abstracts
• View article
• Supplementary data

Intestinal ultrasound as a prognostic tool in new-onset ulcerative colitis—a Copenhagen IBD Cohort Study

• Abstract
• View article
• Supplementary data

GLP-1 Analog Use is Associated With Improved Disease Course in Inflammatory Bowel Disease: A Report from the Epi-IIRN

• Abstracts
• View article
• Supplementary data

The Substantial Role of Sleep, Stress, and Physical Activity in Persistent High Levels of Fatigue in Patients With Inflammatory Bowel Disease: A Longitudinal Trajectory Study

• Abstract
• View article
• Supplementary data

Risankizumab Is Associated With Normalization of Biomarkers in Patients With Crohn’s Disease: Results From the Phase 3 ADVANCE, MOTIVATE, and FORTIFY Studies

• Abstracts
• View article
• Supplementary data

Labor Market Participation and Income in Patients With Inflammatory Bowel Disease Onset Before Young Adulthood—The Role of Disease Severity and Mental Health

• Abstract
• View article
• Supplementary data

Impact of Histological Remission for Predicting Clinical Relapse in Crohn’s Disease: A Post Hoc Analysis of the Prospective STORI Cohort

• Abstract
• View article
• Supplementary data

Fatigue in Patients with Inflammatory Bowel Disease in Remission One Year After Diagnosis (the IBSEN III Study)

• Abstract
• View article
• Supplementary data

Use of Modified Multiplier of the Simple Endoscopic Score for Crohn’s Disease Endoscopic Improvement Thresholds Enhances Effect Size Differentiation Between Adalimumab Versus Placebo: A Post Hoc Analysis of the EXTEND Trial

• Abstracts
• View article
• Supplementary data